Top Markets
#1 Status Status +19.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 GoPlus Security GoPlus Security +14.26%
#4 Ontology Gas Ontology Gas +12.27%
#5 DMT-NAT DMT-NAT +8.99%
#6 Nillion Nillion +7.04%
#7 Provenance Blockchain Provenance Blockchain +7.02%
#8 Janction Janction +6.49%
#9 Cap Cap +6.34%
#10 Bedrock Bedrock +5.75%
Coin of the day
Status Status
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rang in aandelen #34154
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Aandeelprijs
$0.617
Laatst gesynchroniseerd: 2024-10-14
Marktkapitalisatie
$6.13M
Verandering (1 dag)
0.49%
Verandering (1 jaar)
0.00%
Land
US
Handel Kineta, Inc. (KA)

Categorie

Healthcare
Koersgeschiedenis voor Kineta, Inc. (KA)
Hoogste slotkoers: $0.60 op 2024-10-01

Laagste slotkoers: $660.46 op 2016-02-01
Koersgeschiedenis van Kineta, Inc. van 2016 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 -85.01%
2023 -51.01%
2022 -54.76%
2021 -84.38%
2020 -61.46%
2019 -35.59%
2018 -2.25%
2017 -61.49%
2016 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE